Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD-MSCs Plus Calcipotriol for Moderate to Severe Psoriasis
NCT03392311Phase 2Completed
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jul 2019
- Primary completion
- Oct 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of adipose derived mesenchymal stromal cells in psoriasis, sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Improvement rate of PASI at 12 weeks. Started Jul 2019; status: completed.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT03392311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03392311.